International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Page 67 , April 2010

Diphenylhydantoin and insulinoma

Received 7 October 2009 ,Accepted 5 December 2009.

References 

  1. Nabbout LA, Salti IS, Merheb MT. Medical treatment of insulinomas: The role of diphenylhydantoin. Int J Diabetes. 2009;1:35–37
  2. Imanaka S, Matsuda S, Ito K, Matsuoka T, Okada Y. Studies on the medical treatment of non-operable insulinoma. Clinical usefulness of diphenylhydantoin-calcium antagonist. Nippon Naika Gakkai Zasshi. 1985;74(5):590–596
  3. Imanaka S, Matsuda S, Ito K, Matsuoka T, Okada Y. Medical treatment for inoperable insulinoma: clinical usefulness of diphenylhydantoin and diltiazem. Jpn J Clin Oncol. 1986;16(1):65–71

PII: S1877-5934(09)00058-7

doi: 10.1016/j.ijdm.2009.12.001

International Journal of Diabetes Mellitus
Volume 2, Issue 1 , Page 67 , April 2010

Article Tools